Compounds > fangchinoline
Page last updated: 2024-08-25

fangchinoline and Breast Cancer

fangchinoline has been researched along with Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bao, L; He, T; Li, P; Liu, J; Liu, X; Pan, W; Yang, L; Yu, X; Zhang, W1
Bao, L; He, Z; Jiao, Y; Li, H; Liu, J; Lu, H; Pan, W; Yang, S; Zhang, W1
Bu, YQ; Hu, N; Liu, GL; Liu, XJ; Song, FZ; Wan, JY; Wang, CD; Wu, XM; Yuan, CF; Zhang, L; Zu, Y1
Pang, D; Xing, ZB; Yao, L; Zhang, GQ; Zhang, XY; Zhang, YX1
Ma, Y; Pang, D; Xing, Z; Yang, Y; Zhang, X; Zhang, Y1

Other Studies

5 other study(ies) available for fangchinoline and Breast Cancer

ArticleYear
Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Dec-31, Volume: 169

    Topics: Antineoplastic Agents; Benzylisoquinolines; Breast Neoplasms; DNA; Female; Humans; RecQ Helicases; RNA, Messenger

2023
Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase.
    BMC cancer, 2019, Oct-28, Volume: 19, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA; DNA Helicases; DNA-Binding Proteins; Drosophila Proteins; Drug Screening Assays, Antitumor; Escherichia coli; Female; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Protein Binding; RecQ Helicases; Signal Transduction

2019
Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:2

    Topics: Apoptosis; Benzylisoquinolines; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclin D1; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2014
Fangchinoline inhibits breast adenocarcinoma proliferation by inducing apoptosis.
    Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:12

    Topics: Adenocarcinoma; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Breast Neoplasms; Caspases; Cell Line, Tumor; Cytochromes c; DNA Fragmentation; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Neoplastic; Humans; Proto-Oncogene Proteins c-bcl-2; Stephania tetrandra

2011
Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
    Phytotherapy research : PTR, 2013, Volume: 27, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D3; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; G1 Phase; Humans; Oncogene Proteins

2013